Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by GlobalData.
The Apple iPhone 14 features a 6.1-inch Super Retina XDR OLED display with HDR10 certification. At its core is Apple’s in-house 5nm A15 Bionic SoC coupled with 6GB of RAM. There is a dual-camera ...
Starbucks (NASDAQ:SBUX – Free Report) had its price target decreased by Stifel Nicolaus from $110.00 to $105.00 in a research note released on Wednesday, Benzinga reports. Stifel Nicolaus currently ...